Abstract 7010: HDB-82: A promising PROTAC degrader for KRAS G12D mutant cancers

克拉斯 突变体 癌症 医学 内科学 癌症研究 肿瘤科 生物 遗传学 基因 结直肠癌
作者
Mohammad Hassan Baig,Yun Seong Jo,Sagar D. Nale,Chang Joong Kim,Tae Hwan Park,Ju Han Bok,Dong‐Min Kim,Hye Mi Kim,Ji Min Park,Jae-June Dong,Jae Hee Cho,Sung Ill Jang,Byoung Gon Moon
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:85 (8_Supplement_1): 7010-7010 被引量:1
标识
DOI:10.1158/1538-7445.am2025-7010
摘要

Abstract KRAS G12D mutations, occurring in approximately 30% of solid tumors, represent a significant therapeutic target. While selective KRAS G12C inhibitors have achieved clinical success, effectively targeting the more prevalent G12D mutation remains an unmet medical need. This study investigates the potential of proteolysis-targeting chimeras (PROTACs) as a promising avenue for KRAS G12D-driven cancers, potentially offering advantages over traditional inhibitors through catalytic protein degradation. Targeted protein degradation of mutant KRAS may yield greater efficacy than simply inhibiting the protein. This study focuses on the design, synthesis, and biological evaluation of novel KRAS G12D-targeting PROTAC degraders. Through rigorous optimization, we developed HDB-82, a highly potent and selective PROTAC compound targeting KRAS G12D. HDB-82 effectively induced degradation of the KRAS G12D protein, leading to significant antiproliferative activity against KRAS G12D-mutant cancer cells in vitro and in vivo. HDB-82 demonstrated potent anti-cancer activity against various KRAS G12D-mutant cell lines, achieving low nanomolar IC50 values. It effectively degraded the KRAS G12D protein in various KRAS G12D-expressing cell lines (DC50 value ranges from picomolar to sub-nanomolar range). Mechanistic studies revealed significant suppression of downstream MAPK and PI3K/AKT signaling pathways, accompanied by robust induction of apoptosis, and superior antiproliferative activity compared to existing inhibitors. Furthermore, HDB-82 exhibited favorable pharmacokinetic and pharmacodynamic properties in mice. Intravenous administration of HDB-82 (10 mg/kg, q.w.) resulted in substantial tumor growth inhibition across multiple KRAS G12D-positive tumor models. These findings establish HDB-82 as a promising therapeutic candidate for KRAS G12D-mutant cancers, warranting further preclinical investigation and potential clinical development. Citation Format: Mohammad Hassan Baig, Yun Seong Jo, Sagar Dattatraya Nale, Chang Joong Kim, Tae Hwan Park, Ju Han Bok, Dong Min Kim, Hye Mi Kim, Ji Min Park, Jae June Dong, Jae Hee Cho, Sung Ill Jang, Byoung Gon Moon. HDB-82: A promising PROTAC degrader for KRAS G12D mutant cancers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 7010.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
搞论文小白完成签到 ,获得积分10
刚刚
犹豫的若发布了新的文献求助10
刚刚
睎林发布了新的文献求助10
刚刚
赖葡萄发布了新的文献求助10
刚刚
每天100次完成签到,获得积分10
1秒前
Pan发布了新的文献求助10
1秒前
1秒前
爆米花的应助被linyuiz采纳,获得10
2秒前
SSSYYY完成签到,获得积分10
2秒前
YZ_Yue完成签到,获得积分10
2秒前
帅气的祥发布了新的文献求助10
3秒前
且行发布了新的文献求助10
3秒前
大个的应助被xx采纳,获得10
3秒前
qiyue完成签到,获得积分10
3秒前
何桉发布了新的文献求助10
3秒前
leotao发布了新的文献求助10
3秒前
lixingshuai完成签到,获得积分10
3秒前
3秒前
科研通AI6.2的应助被来来来采纳,获得10
4秒前
完美世界的应助被淡淡的冥茗采纳,获得10
4秒前
richard_cn2026完成签到,获得积分20
4秒前
4秒前
4秒前
万能图书馆的应助被CKK采纳,获得10
5秒前
斯文败类的应助被曹文采纳,获得10
5秒前
Hello的应助被柴火妞采纳,获得10
5秒前
6秒前
利好完成签到,获得积分10
6秒前
6秒前
星辰大海的应助被令嘉采纳,获得30
6秒前
知了完成签到 ,获得积分10
7秒前
BulePie的应助被子时过采纳,获得10
7秒前
7秒前
小陈完成签到 ,获得积分10
7秒前
明天见完成签到,获得积分20
7秒前
陈早早发布了新的文献求助10
7秒前
念0完成签到 ,获得积分10
8秒前
方妙竹完成签到,获得积分10
8秒前
归途完成签到 ,获得积分10
8秒前
荼蘼发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180807
求助须知:如何正确求助?哪些是违规求助? 9570895
关于积分的说明 21815089
捐赠科研通 7777155
什么是DOI,文献DOI怎么找? 3433347
关于科研通互助平台的介绍 2557613
邀请新用户注册赠送积分活动 2479317